India, Sept. 18 -- Spanish company Pharmactive Biotech Products, S.L., launches its Affron(R) all-natural, non-GMO Spanish saffron extract ( Crocus sativus L.) in the Asia-Pacific market. The company's formulation boasts the lowest dosage threshold on the market - just 28mg per day - with proven pharmacokinetic bioavailability and rapid one-hour absorption.

Pharmactive will launch Affron at Vitafoods Asia 2019 in Singapore, Booth #I32, on 25-26 September 2019, where the Affron format for eye health, Affron(R) EYE, is one the finalists for the Nutraingredients Awards Asia in the field of Healthy Ageing.

Affron is standardized to Lepticrosalides(R), a complex of bioactive compounds responsible for the beneficial and organoleptic attribute...